SCHEMBL6076118

SCHEMBL6076118

CCOC(=O)C(CC)(C(=O)OCC)[C@@H](C(=O)O)c1ccccc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 2/20 0.44
ALDH1A1 P00352 2/20 0.40
MMP8 P22894 2/20 0.40
RECQL P46063 1/20 0.40
POLB P06746 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ACP3 P15309 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 1/20 0.38
TSHR P16473 1/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
CASP1 P29466 1/20 0.36
ESR1 P03372 1/20 0.36
NLRP3 Q96P20 1/20 0.36
MAPT P10636 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6075831 0.85 PIN1 (0.38) PIN1ALDH1A1MMP8RECQLPOLB
SCHEMBL16795787 0.73 PIN1 (0.41) PIN1ALDH1A1MMP8RECQLPOLB
SCHEMBL27816341 0.73 MMP8 (0.51) PIN1ALDH1A1MMP8POLBMEN1
SCHEMBL363983 0.71 TSHR (0.48) PIN1ALDH1A1MMP8MEN1KMT2A
SCHEMBL7509738 0.71 MMP8 (0.51) PIN1ALDH1A1MMP8POLBMEN1
SCHEMBL8111908 0.70 CASP1 (0.48) PIN1ALDH1A1MMP8RECQLACP3
SCHEMBL27512117 0.70 PPARA (0.41) PIN1POLBACP3MEN1KMT2A
SCHEMBL27774182 0.70 MMP8 (0.44) PIN1ALDH1A1MMP8RECQLPOLB
SCHEMBL1190661 0.69 CASP1 (0.49) PIN1MMP8POLBMEN1KMT2A
SCHEMBL9127785 0.68 TDP1 (0.45) PIN1ALDH1A1MMP8POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115633-B2 Central nervous system disorders; Alzheimer's diseases; eating disorders GLAXOSMITHKLINE S.P.A. (IT) 2006-10-03 US disclosed
US-20040029917-A1 Benzosuberonylpiperdine compounds as analgesics GLAXOSMITHKLINE S.P.A. (IT) 2004-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029917-A1 Benzosuberonylpiperdine compounds as analgesics OPRK1, OPRL1, OPRM1 PIN1 4655/4885ALDH1A1 99/4885MMP8 3000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.